Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin (25mg) + Linagliptin (5mg) + Metformin (1000mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Emplozin LM 25 Tablet containing Empagliflozin, Linagliptin, and Metformin is used for the management of type 2 diabetes mellitus. It helps improve blood sugar control and supports better glycemic balance.
Empagliflozin works by removing excess glucose through urine, Linagliptin helps increase insulin release and reduce glucose production, while Metformin improves insulin sensitivity and decreases hepatic glucose output.
The tablet is widely prescribed in endocrinology and general medicine practice for advanced diabetes management, leading to consistent prescription demand.
With increasing prevalence of diabetes and lifestyle-related metabolic disorders, this product offers strong business potential for retailers and distributors. Its triple-action glucose control mechanism, broad clinical relevance, and steady market demand make it a reliable product for growth in the anti-diabetic segment.
Some patients may experience nausea, diarrhea, increased urination, urinary tract infections, headache, or abdominal discomfort. Rarely, pancreatitis, dehydration, ketoacidosis, or lactic acidosis may occur and require immediate medical attention.
Emplozin LM 25 Tablet is indicated for type 2 diabetes mellitus in patients requiring combination therapy for better glycemic control. It helps lower fasting and post-meal blood sugar levels, improve insulin utilization, and support long-term diabetes management.
This medicine should be used under medical supervision along with a healthy diet and regular exercise. Regular monitoring of blood glucose, kidney function, and hydration status is recommended. Avoid excessive alcohol consumption during treatment.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) Tablet
Composition : Empagliflozin (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Emplozin LM 25 Tablet has strong demand in the anti-diabetic and metabolic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetology and chronic-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of type 2 diabetes mellitus, uncontrolled blood sugar levels, insulin resistance, and diabetes-related metabolic conditions. Empagliflozin 25mg helps remove excess glucose through urine and supports cardiovascular benefits Linagliptin 5mg helps improve insulin secretion and blood sugar control Metformin 1000mg helps reduce glucose production and improve insulin sensitivity Together, this triple-combination tablet provides comprehensive blood sugar management and strengthens a reliable anti-diabetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Emplozin LM 25 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong diabetologist and physician prescriptions, chronic long-term therapy demand, growing diabetic-care market, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.